BELNACASAN Drug Record

  • BELNACASAN chembl:CHEMBL2107819

    Alternate Names:

    BELNACASAN
    VX-765

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antipsoriatic agent,anticonvulsant
    (0 More Sources)

    Publications:

  • BELNACASAN   CASP1

    Interaction Score: 5.38

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name VX-765
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • TdgClinicalTrial: VX-765

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antipsoriatic agent,anticonvulsant
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • TTD: Belnacasan

    • Version: 2020.06.01

    Alternate Names:
    D0HK3N TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2107819

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: